Combination of Paclitaxel and MG1 oncolytic virus as a successful strategy for breast cancer treatment

BACKGROUND: Breast cancer is the most common malignant disease amongst Western women. The lack of treatment options for patients with chemotherapy-resistant or recurrent cancers is pushing the field toward the rapid development of novel therapies. The use of oncolytic viruses is a promising approach...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Breast Cancer Res
Autores principales: Bourgeois-Daigneault, Marie-Claude, St-Germain, Lauren Elizabeth, Roy, Dominic Guy, Pelin, Adrian, Aitken, Amelia Sadie, Arulanandam, Rozanne, Falls, Theresa, Garcia, Vanessa, Diallo, Jean-Simon, Bell, John Cameron
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4977613/
https://ncbi.nlm.nih.gov/pubmed/27503504
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-016-0744-y
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares